AI
LAB icon

Atom Investors’s Standard BioTools LAB Stock Holding History

Atom Investors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Buy
+29,576
New +$27.9K ﹤0.01% 817
2021
Q1 		– Sell
-2,911,002
Closed -$17.5M – 345
2020
Q4 		$17.5M Sell
2,911,002
-294,400
-9% -$1.93M 1.76% 6
2020
Q3 		$23.8M Buy
+3,205,402
New +$22.1M 2.27% 5

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Atom Investors's LAB Position: Q2 2026 in Review

Atom Investors opened a new position in Standard BioTools (LAB) in Q2 2026: 29,576 shares worth $24.3K. The stake represents ﹤0.01% of the portfolio and ranks #817 among its holdings. This is a return to the name: Atom Investors previously reported a position in LAB as recently as Q4 2020.

Atom Investors first reported a position in LAB in Q3 2020 and has held it in 3 quarters since. The position peaked at $23.8M in Q3 2020. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Atom Investors held 29,576 shares of Standard BioTools worth $24.3K as of Q2 2026.
  • Standard BioTools was a new Atom Investors position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Atom Investors's portfolio in Q2 2026, its #817 holding.
  • Atom Investors first reported a position in Standard BioTools in Q3 2020 and has held it in 3 quarters since.
  • Atom Investors's Standard BioTools position peaked at $23.8M in Q3 2020.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.